US tuberculosis cases were at the highest level in a decade in 2023

by Mike StobbeThis 1966 microscope photo provided by the U.S. Centers for Disease Control and Prevention shows Mycobacterium tuberculosis bacilli, the organism responsible for causing the disease tube

Updated on: April 30,2024 0

US tuberculosis cases were at the highest level in a decade in 2023

by Mike StobbeThis 1966 microscope photo provided by the U.S. Centers for Disease Control and Prevention shows Mycobacterium tuberculosis bacilli, the organism responsible for causing the disease tube

Updated on:April 30,2024 0

HIV-1 protein suppresses immune response more broadly than thought

by eLifeHIV-1 Virus. Credit: J Roberto Trujillo/WikipediaScientists have revealed how a protein produced by HIV-1 plays a broader role in suppressing the immune system's response to infection

Updated on: April 16,2024 15

HIV-1 protein suppresses immune response more broadly than thought

by eLifeHIV-1 Virus. Credit: J Roberto Trujillo/WikipediaScientists have revealed how a protein produced by HIV-1 plays a broader role in suppressing the immune system's response to infection

Updated on:April 16,2024 15

How SARS-CoV-2 evades the immune system

by Hokkaido UniversityThe expression of the immune response gene NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells (Photo: Koichi Kobayashi). Credit: Koichi KobayashiResearche

Updated on: April 22,2024 12

How SARS-CoV-2 evades the immune system

by Hokkaido UniversityThe expression of the immune response gene NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells (Photo: Koichi Kobayashi). Credit: Koichi KobayashiResearche

Updated on:April 22,2024 12

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on: March 27,2024 0

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on:March 27,2024 0

SARS-CoV-2 variants, including mutated variants resembling omicron, are evolving new ways to evade antibodies, vaccines

by Jake Miller,Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainIn an effort to predict future evolutionary maneuvers of SARS-CoV-2, a research team led by investigators at Harvard Medical

Updated on: April 22,2024 13

SARS-CoV-2 variants, including mutated variants resembling omicron, are evolving new ways to evade antibodies, vaccines

by Jake Miller,Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainIn an effort to predict future evolutionary maneuvers of SARS-CoV-2, a research team led by investigators at Harvard Medical

Updated on:April 22,2024 13

Study links key gene to protection from severe illness and death from COVID infections in men under age 75

by David March,NYU Langone HealthGraphical Abstract. Credit:The Journal of Infectious Diseases(2024). DOI: 10.1093/infdis/jiae031A certain variant of a key anti-inflammatory gene pro

Updated on: March 20,2024 13

Study links key gene to protection from severe illness and death from COVID infections in men under age 75

by David March,NYU Langone HealthGraphical Abstract. Credit:The Journal of Infectious Diseases(2024). DOI: 10.1093/infdis/jiae031A certain variant of a key anti-inflammatory gene pro

Updated on:March 20,2024 13

Meningococcal disease on the rise in the US

by Deb Balzer,Mayo ClinicNeisseria meningitidisbacteria, responsible for causing meningococcal meningitis. Credit: CDCA rise in invasive serogroup Y meningococcal disease has prompted the

Updated on: April 30,2024 0

Meningococcal disease on the rise in the US

by Deb Balzer,Mayo ClinicNeisseria meningitidisbacteria, responsible for causing meningococcal meningitis. Credit: CDCA rise in invasive serogroup Y meningococcal disease has prompted the

Updated on:April 30,2024 0

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on: April 02,2024 16

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on:April 02,2024 16

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe

Updated on: April 12,2024 19

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe

Updated on:April 12,2024 19

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on: April 22,2024 20

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on:April 22,2024 20

Drug repurposing research offers new hope in the fight against RSV

by Jan Grabowski, Zentrum für Experimentelle und Klinische InfektionsforschungIdentification of drug repurposing candidates.AScreening and validation procedure.BHEp-2 cells wer

Updated on: May 21,2024 3

Drug repurposing research offers new hope in the fight against RSV

by Jan Grabowski, Zentrum für Experimentelle und Klinische InfektionsforschungIdentification of drug repurposing candidates.AScreening and validation procedure.BHEp-2 cells wer

Updated on:May 21,2024 3

Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on: March 20,2024 20

Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on:March 20,2024 20